PMID: 7017681Jan 1, 1980Paper

Steroids and rejection treatment in the Gothenburg transplant programme

Proceedings of the European Dialysis and Transplant Association
H Brynger, L E Gelin

Abstract

Our experience from the Gothenburg material indicates that the graft prognosis is highly dependent on pretransplant blood transfusions, to a lesser degree on avoidance of two mismatches for the HLA-B-locus and, not the least, on the use of methylprednisolone antirejection therapy. It seems that a rather moderate dosage of methylprednisolone allows us to prolong and repeat the courses according to individual needs, and this may be the main reason for the significantly improved graft function at one year. The experiences gained and the lessons learned from the transplant programme in Gothenburg have resulted in 70% of the uraemic patients in the Gothenburg region being alive with functioning renal transplants.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Proceedings of the European Dialysis and Transplant Association
H BryngerL E Gelin
Proceedings of the European Dialysis and Transplant Association
T J BuselmeierR W Goltz
Scandinavian Journal of Urology and Nephrology. Supplementum
H Gäbel, H Brynger
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
G Sunder-Plassmann, W H Hörl
© 2021 Meta ULC. All rights reserved